{"id":"https://openalex.org/W1968777919","doi":"https://doi.org/10.1111/j.1365-2125.1983.tb02218.x","title":"Induction of propranolol metabolism by rifampicin.","display_name":"Induction of propranolol metabolism by rifampicin.","publication_year":1983,"publication_date":"1983-11-01","ids":{"openalex":"https://openalex.org/W1968777919","doi":"https://doi.org/10.1111/j.1365-2125.1983.tb02218.x","mag":"1968777919","pmid":"https://pubmed.ncbi.nlm.nih.gov/6639842","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1428059"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2125.1983.tb02218.x","doi":"https://doi.org/10.1111/j.1365-2125.1983.tb02218.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.1983.tb02218.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1983.tb02218.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1983.tb02218.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036480570","display_name":"RJ Herman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"RJ Herman","raw_affiliation_strings":["Departments of Medicine and Pharmacology, Vanderbilt University, Nashville, TN 37232, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine and Pharmacology, Vanderbilt University, Nashville, TN 37232, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103075935","display_name":"K\u014dichi Nakamura","orcid":"https://orcid.org/0000-0003-2330-7032","observed_orcids":["https://orcid.org/0000-0003-2330-7032","https://orcid.org/0009-0006-3990-7429"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K Nakamura","raw_affiliation_strings":["Departments of Medicine and Pharmacology, Vanderbilt University, Nashville, TN 37232, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine and Pharmacology, Vanderbilt University, Nashville, TN 37232, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107195750","display_name":"GR Wilkinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"GR Wilkinson","raw_affiliation_strings":["Departments of Medicine and Pharmacology, Vanderbilt University, Nashville, TN 37232, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine and Pharmacology, Vanderbilt University, Nashville, TN 37232, USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110090151","display_name":"AJ Wood","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"AJ Wood","raw_affiliation_strings":["Departments of Medicine and Pharmacology, Vanderbilt University, Nashville, TN 37232, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicine and Pharmacology, Vanderbilt University, Nashville, TN 37232, USA","institution_ids":["https://openalex.org/I200719446"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I200719446"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":2.4047,"has_fulltext":true,"cited_by_count":53,"citation_normalized_percentile":{"value":0.8761655,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"16","issue":"5","first_page":"565","last_page":"569"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rifampicin","display_name":"rifampicin","score":0.9240000247955322},{"id":"https://openalex.org/keywords/propranolol","display_name":"propranolol","score":1.0},{"id":"https://openalex.org/keywords/drug-metabolism-induction","display_name":"drug metabolism induction","score":0.6520000100135803},{"id":"https://openalex.org/keywords/enzyme-induction","display_name":"enzyme induction","score":0.6899999976158142},{"id":"https://openalex.org/keywords/oral-clearance","display_name":"oral clearance","score":0.8610000014305115},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.9800000190734863},{"id":"https://openalex.org/keywords/plasma-protein-binding","display_name":"plasma protein binding","score":0.7580000162124634},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.8610000014305115},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.734000027179718}],"concepts":[{"id":"https://openalex.org/C2778607973","wikidata":"https://www.wikidata.org/wiki/Q422652","display_name":"Rifampicin","level":3,"score":0.8441588878631592},{"id":"https://openalex.org/C2778151854","wikidata":"https://www.wikidata.org/wiki/Q423364","display_name":"Propranolol","level":2,"score":0.8231817483901978},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.7031122446060181},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6042376756668091},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5691612362861633},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5618478655815125},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5261677503585815},{"id":"https://openalex.org/C3941253","wikidata":"https://www.wikidata.org/wiki/Q47270","display_name":"Half-life","level":3,"score":0.5204532146453857},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3880367875099182},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3245046138763428},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004790","descriptor_name":"Enzyme Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010634","descriptor_name":"Phenobarbital","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011433","descriptor_name":"Propranolol","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1365-2125.1983.tb02218.x","doi":"https://doi.org/10.1111/j.1365-2125.1983.tb02218.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.1983.tb02218.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1983.tb02218.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1428059","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1428059","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:6639842","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6639842","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1111/j.1365-2125.1983.tb02218.x","doi":"https://doi.org/10.1111/j.1365-2125.1983.tb02218.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2125.1983.tb02218.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.1983.tb02218.x","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1968777919.pdf","grobid_xml":"https://content.openalex.org/works/W1968777919.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W74649421","https://openalex.org/W1775964807","https://openalex.org/W1897589704","https://openalex.org/W1964758561","https://openalex.org/W1977435829","https://openalex.org/W1981125655","https://openalex.org/W1983920076","https://openalex.org/W2009955124","https://openalex.org/W2012110786","https://openalex.org/W2044951617","https://openalex.org/W2046526330","https://openalex.org/W2061357234","https://openalex.org/W2063515260","https://openalex.org/W2066806870","https://openalex.org/W2080069602","https://openalex.org/W2083167659","https://openalex.org/W2086068617","https://openalex.org/W2092637448","https://openalex.org/W2098871987","https://openalex.org/W2226961199","https://openalex.org/W2233492637","https://openalex.org/W2244265701","https://openalex.org/W2335954545","https://openalex.org/W2339179533","https://openalex.org/W2396536432","https://openalex.org/W2397543233","https://openalex.org/W2401031788","https://openalex.org/W2414042722","https://openalex.org/W2415041649","https://openalex.org/W2416488019","https://openalex.org/W2440354756","https://openalex.org/W4238902734","https://openalex.org/W4300852529","https://openalex.org/W6639411335"],"related_works":["https://openalex.org/W2086068617","https://openalex.org/W1964758561","https://openalex.org/W2121487961","https://openalex.org/W2158761422","https://openalex.org/W2397543233","https://openalex.org/W2042347442","https://openalex.org/W2030021013","https://openalex.org/W2093506266","https://openalex.org/W2042538807","https://openalex.org/W2040640645"],"abstract_inverted_index":{"The":[0,166,196,213],"effect":[1],"of":[2,9,16,64,69,86,128,169,184,204,240],"rifampicin":[3,43,74,187,201,226],"on":[4],"the":[5,58,65,67,94,123,134,178,185,190,205,217,241,245],"blood":[6,220],"concentration-time":[7],"curve":[8],"propranolol":[10,59,170,219],"at":[11],"steady-state":[12,218],"following":[13],"oral":[14,88,106,149,157,167],"administration":[15,183,227],"120":[17],"mg":[18,42,73,141],"every":[19],"8":[20],"h":[21,194],"was":[22,60,76,171],"investigated":[23],"in":[24,80,104,148,216,233,237],"six":[25],"normal,":[26],"young,":[27],"male":[28],"subjects.":[29],"After":[30],"an":[31],"initial":[32],"2":[33],"week":[34,52],"dosing":[35],"period,":[36],"all":[37],"individuals":[38],"additionally":[39],"received":[40],"600":[41],"daily":[44,75,135],"for":[45,210],"3":[46],"weeks":[47,152],"followed":[48],"by":[49,84],"a":[50,101,234],"4":[51],"period":[53],"during":[54,93,177],"which":[55],"again":[56],"only":[57],"given.":[61],"In":[62],"four":[63],"subjects":[66],"effects":[68],"900":[70,138],"and":[71,90,139],"1200":[72,140],"also":[77],"studied.":[78],"Changes":[79],"disposition":[81],"were":[82,131],"assessed":[83],"estimation":[85],"propranolol's":[87,105,156,211],"clearance":[89,107,158,168],"elimination":[91,124],"half-life":[92,125],"dosage":[95,136,179],"interval.":[96],"Rifampicin":[97],"(600":[98],"mg/day)":[99],"caused":[100],"large":[102],"increase":[103],"(35.7":[108],"+/-":[109,113,119,175],"16.3":[110],"vs":[111],"96.1":[112],"26.9":[114],"ml":[115],"min-1":[116],"kg-1,":[117],"mean":[118],"s.d.),":[120],"but":[121],"neither":[122],"nor":[126],"extent":[127],"plasma":[129],"binding":[130],"affected.":[132],"Increasing":[133],"to":[137,162,231],"did":[142],"not":[143],"cause":[144],"any":[145],"additional":[146],"changes":[147],"clearance.":[150],"Four":[151],"after":[153,182],"discontinuing":[154],"rifampicin,":[155],"had":[159],"essentially":[160],"returned":[161],"its":[163],"pre-induction":[164],"level.":[165],"significantly":[172],"smaller":[173],"(89.5":[174],"14.4%)":[176],"interval":[180],"immediately":[181],"last":[186],"dose":[188],"than":[189],"value":[191],"measured":[192],"24":[193],"later.":[195],"findings":[197],"are":[198,248],"consistent":[199],"with":[200],"causing":[202],"induction":[203],"drug":[206],"metabolizing":[207],"enzymes":[208],"responsible":[209],"biotransformation.":[212],"marked":[214],"reduction":[215],"concentration":[221],"that":[222],"results":[223],"from":[224],"chronic":[225],"would":[228],"be":[229],"expected":[230],"result":[232],"significant":[235],"change":[236],"clinical":[238],"effectiveness":[239],"beta-adrenoceptor":[242],"blocker":[243],"when":[244],"two":[246],"drugs":[247],"used":[249],"concurrently.":[250]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}